0000899243-20-010229.txt : 20200403 0000899243-20-010229.hdr.sgml : 20200403 20200403180447 ACCESSION NUMBER: 0000899243-20-010229 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200403 FILED AS OF DATE: 20200403 DATE AS OF CHANGE: 20200403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SUN ANTHONY Y CENTRAL INDEX KEY: 0001377952 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39263 FILM NUMBER: 20775154 MAIL ADDRESS: STREET 1: C/O AISLING CAPITAL STREET 2: 888 SEVENTH AVENUE, 30TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zentalis Pharmaceuticals, LLC CENTRAL INDEX KEY: 0001725160 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 530 SEVENTH AVENUE, SUITE 2201 CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: (212) 433-3791 MAIL ADDRESS: STREET 1: 530 SEVENTH AVENUE, SUITE 2201 CITY: NEW YORK STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: Zeno Pharma, LLC DATE OF NAME CHANGE: 20171212 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2020-04-03 0 0001725160 Zentalis Pharmaceuticals, LLC ZNTL 0001377952 SUN ANTHONY Y C/O ZENTALIS PHARMACEUTICALS, INC. 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018 1 1 0 0 President & CEO Common Stock 1842288 D Common Stock 974302 I By Essex Group International, LLC Stock Option 18.00 2030-04-02 Common Stock 500000 D Includes 305,372 shares of restricted stock. The option vests and becomes exercisable as to 25% of the shares on April 2, 2021 and vests in equal monthly installments thereafter until April 2, 2024. Exhibit 24 - Power of Attorney. /s/ Melissa B. Epperly, Attorney-in-Fact for Anthony Y. Sun 2020-04-03 EX-24 2 attachment1.htm EX-24 DOCUMENT

                               POWER OF ATTORNEY

    With respect to holdings of and transactions in securities issued by
Zentalis Pharmaceuticals, Inc. (the "Company"), the undersigned hereby
constitutes and appoints Melissa B. Epperly and Kimberley Overs, or any of them
signing singly, with full power of substitution and resubstitution, to act as
the undersigned's true and lawful attorney-in-fact to:

    1.  execute for and on behalf of the undersigned, Schedules 13D and 13G in
        accordance with Section 13 of the Securities Exchange Act of 1934, as
        amended (the "Exchange Act"), and the rules thereunder, and Forms 3, 4,
        and 5 in accordance with Section 16 of the Exchange Act and the rules
        thereunder;

    2.  do and perform any and all acts for and on behalf of the undersigned
        which may be necessary or desirable to complete and execute any such
        Schedule 13D or 13G or Form 3, 4, or 5, complete and execute any
        amendment or amendments thereto, and timely file such schedule or form
        with the SEC and any stock exchange or similar authority; and

    3.  take any other action of any type whatsoever in connection with the
        foregoing which, in the opinion of such attorney-in-fact, may be of
        benefit to, in the best interest of, or legally required by, the
        undersigned, it being understood that the documents executed by such
        attorney-in-fact on behalf of the undersigned pursuant to this Power of
        Attorney shall be in such form and shall contain such terms and
        conditions as such attorney-in-fact may approve in such attorney-in-
        fact's discretion.

    The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution and
resubstitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorneys-in-fact substitute or substitutes, shall
lawfully do or cause to be done by virtue of this Power of Attorney and the
rights and powers herein granted.

    The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 13 and Section 16 of the Exchange Act.

    This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Schedule 13D and 13G and Forms 3, 4,
and 5 with respect to the undersigned's holdings of and transactions in
securities issued by the Company, unless earlier revoked by the undersigned in a
signed writing delivered to the foregoing attorneys-in-fact.

    IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 17th day of March, 2020.


                                            /s/ Anthony Y. Sun
                                            -----------------------
                                            Anthony Y. Sun, M.D.